Rothschild Investment LLC’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29K Hold
193
﹤0.01% 1422
2026
Q1
$17.8K Buy
193
+2
+1% +$201 ﹤0.01% 1467
2025
Q4
$19.5K Buy
191
+11
+6% +$984 ﹤0.01% 1330
2025
Q3
$11.2K Sell
180
-65
-27% -$3.54K ﹤0.01% 1396
2025
Q2
$12.8K Buy
245
+25
+11% +$1.12K ﹤0.01% 1144
2025
Q1
$9.37K Buy
220
+75
+52% +$3.24K ﹤0.01% 1186
2024
Q4
$4.43K Buy
145
+35
+32% +$985 ﹤0.01% 1393
2024
Q3
$2.52K Buy
110
+55
+100% +$1.56K ﹤0.01% 1609
2024
Q2
$1.59K Buy
55
+45
+450% +$1.05K ﹤0.01% 1474
2024
Q1
$206 Buy
+10
New +$214 ﹤0.01% 1730

Other funds holding GH

Rothschild Investment LLC's GH Position: Q2 2026 in Review

Rothschild Investment LLC held its Guardant Health (GH) position steady in Q2 2026 at 193 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Rothschild Investment LLC first reported a position in GH in Q1 2024 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Rothschild Investment LLC held 193 shares of Guardant Health worth $29K as of Q2 2026.
  • Rothschild Investment LLC left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1422 holding.
  • Rothschild Investment LLC first reported a position in Guardant Health in Q1 2024 and has held it in 10 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.